RFP | October 21, 2014
U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases announces the availability of funding for implementation of the Elucidating HIV and HIV-Treatment Associated Metabolic/Endocrine Dysfunction (R01) Grant. The purpose of this grant is to support innovative research in humans to elucidate the role of HIV infection, including relevant host conditions or antiretroviral therapy, on metabolic and endocrine dysfunction, as well as to support innovative research delineating the pathophysiology, etiology, risk or protective factors, and potential strategies to prevent, treat, or reverse endocrine and metabolic dysfunction in . . .